We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Endovascular Treatment of Right Heart Masses Utilizing the AngioVac System: A 6-Year Single-Center Observational Study.
- Authors
Katapadi, Aashish; Richards, Lauren; Fischer, William; Allaqaband, Suhail Q.; Bajwa, Tanvir; Jan, M. Fuad
- Abstract
<bold>Objective: </bold>To describe our institution's experience with the AngioVac system.<bold>Background: </bold>Intracardiac and intravascular masses previously required surgical excision, but now, there are a number of minimally invasive options. With the advent of vacuum aspiration, more specifically the AngioVac System (AngioDynamics, NY, USA), there exists a system with both low mortality and minor complications. However, the number of retrospective studies remains limited. Outcome data for high-risk patients are also limited.<bold>Methods: </bold>Data were collected and analyzed in patients who underwent AngioVac therapy at our tertiary care center from January 2014 to December 2020.<bold>Results: </bold>Our results demonstrated a 93.3% intraoperative success rate and a 100% intraoperative survival rate. However, a number of complications, including but not limited to hematomas, anemia, and hypotension, occurred, as described below.<bold>Conclusions: </bold>Our experiences demonstrated good outcomes and continue to support the usefulness of the AngioVac System. The data also support the use of AngioVac as a treatment option for the debulking or removal of right heart masses in critically ill patients.
- Subjects
NEW York (N.Y.); ENDOVASCULAR surgery; SURVIVAL rate; SURGICAL excision; SCIENTIFIC observation; HEART; CRITICALLY ill; THROMBOSIS; RETROSPECTIVE studies; VEIN surgery; PRODUCT design; TREATMENT effectiveness; THROMBECTOMY
- Publication
Journal of Interventional Cardiology, 2021, p1
- ISSN
0896-4327
- Publication type
journal article
- DOI
10.1155/2021/9923440